Lack of evidence raises questions on long-term PPI use

There is rising concern over the side effects of long-term proton pump inhibitor (PPI) use but limited evidence to warrant discontinuation, a literature review...

PSA: embed pharmacists to reduce medicine harm in aged care

PSA has called for a national program that embeds pharmacists in all aged care facilities in its submission to the Royal Commission into Aged...

Australia excels on the global pharmacy stage

Australian pharmacy professionals have received top honours at the 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences in Glasgow, while PSA has been...

Opinion: When a natural disaster hits

Dispensing from a house, a library and evacuation centres: that’s what happens in a flood. It’s almost 10 years since a flood put the majority...

Non-steroidal care for the treatment and management of mild eczema and...

Dermal Therapy offers a comprehensive range of clinically tested products to treat and manage the symptoms associated with mild eczema and dermatitis.

Call for pharmacist access to the MBS for Chronic Disease Management

Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense. After a...